Shares Of A Biotech Company That DIDN'T Make The Drug That Saved The Ebola-Infected Doctor Are Surging
Advertisement
REUTERS/Frederick Murphy/CDC/Handout
Advertisement
ZMapp was developed by Mapp Biopharmaceutical, a privately held company.
It's not to be confused with MAP Pharmceuticals, which was acquired by Allergan in 2013.
Tekmira Pharmaceuticals, which also has an experimental ebola drug in the works, is up by around 5% in pre-market trading. It's unclear why.
Here's the after-hours and pre-market moves in Tekmira according to MarketWatch.
Advertisement
Advertisement
- Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
- I tutor the children of some of Dubai's richest people. One of them paid me $3,000 to do his homework.
- India not benefiting from democratic dividend; young have a Kohli mentality, says Raghuram Rajan
- Indo-Gangetic Plains, home to half the Indian population, to soon become hotspot of extreme climate events: study
- 7 Vegetables you shouldn’t peel before eating to get the most nutrients
- Gut check: 10 High-fiber foods to add to your diet to support digestive balance
- 10 Foods that can harm Your bone and joint health
- 6 Lesser-known places to visit near Mussoorie